Tenitramine: Difference between revisions
No edit summary |
m Protected "Tenitramine": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
(No difference)
|
Latest revision as of 17:13, 20 August 2015
Names | |
---|---|
IUPAC name
2-[2-[bis(2-nitrooxyethyl)amino]ethyl-(2-nitrooxyethyl)amino]ethyl nitrate
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
PubChem CID
|
|
UNII | |
| |
| |
Properties | |
C10H20N6O12 | |
Molar mass | 416.30 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
WikiDoc Resources for Tenitramine |
Articles |
---|
Most recent articles on Tenitramine Most cited articles on Tenitramine |
Media |
Powerpoint slides on Tenitramine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Tenitramine at Clinical Trials.gov Clinical Trials on Tenitramine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Tenitramine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Tenitramine Discussion groups on Tenitramine Patient Handouts on Tenitramine Directions to Hospitals Treating Tenitramine Risk calculators and risk factors for Tenitramine
|
Healthcare Provider Resources |
Causes & Risk Factors for Tenitramine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tenitramine (trade name Tinitran) is a nitrovasodilator.